Comparison between Chandra Bhagat Pharma IPO and Gian Life Care IPO.
Chandra Bhagat Pharma IPO is a SME Fixed Price IPO proposed to list at BSE SME while Gian Life Care IPO is a SME Fixed Price proposed to list at BSE SME.
| Chandra Bhagat Pharma IPO | Gian Life Care IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | BSE SME | BSE SME |
| Lead Managers | Beeline Broking Ltd. | Hem Securities Ltd. |
| Registrar | MUFG Intime India Pvt.Ltd. | Cameo Corporate Services Ltd. |
| Market Maker | Beeline Broking Ltd. | Shreni Shares Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Chandra Bhagat Pharma IPO is up to ₹9.69 Cr whereas the issue size of the Gian Life Care IPO is up to ₹2.96 Cr. The final issue price of Chandra Bhagat Pharma IPO is ₹51.00 per share and of Gian Life Care IPO is ₹22.00 per share.
| Chandra Bhagat Pharma IPO | Gian Life Care IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹51.00 per share | ₹22.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 2000 shares | 6000 shares |
| Fresh Issue Size | 19,00,000 shares | 13,44,000 shares |
| Fresh Issue Size (Amount) | up to ₹9.69 Cr | up to ₹2.96 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 19,00,000 shares | 13,44,000 shares |
| Issue Size Total (Amount) | up to ₹9.69 Cr | up to ₹2.96 Cr |
Chandra Bhagat Pharma IPO opens on Jan 31, 2020, while Gian Life Care IPO opens on Dec 31, 2019. The closing date of Chandra Bhagat Pharma IPO and Gian Life Care IPO is Feb 06, 2020, and Jan 03, 2020, respectively.
| Chandra Bhagat Pharma IPO | Gian Life Care IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Jan 31, 2020 | Dec 31, 2019 |
| Issue Close | Feb 06, 2020 | Jan 03, 2020 |
| Basis Of Allotment (Tentative) | Feb 11, 2020 | Jan 08, 2020 |
| Initiation of Refunds (Tentative) | Feb 13, 2020 | Jan 09, 2020 |
| Credit of Share (Tentative) | Feb 13, 2020 | Jan 10, 2020 |
| Listing date (Tentative) | Feb 14, 2020 | Jan 13, 2020 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Chandra Bhagat Pharma IPO P/E ratio is 51, as compared to Gian Life Care IPO P/E ratio of 21.36.
| Chandra Bhagat Pharma IPO | Gian Life Care IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 96.72 | 95.74 | ||||
| Promoter Shareholding (Post-Issue) | 71.08 | 65.62 | ||||
| P/E Ratio | 51 | 21.36 | ||||
| Market Cap | ₹38.48 Cr. | ₹10.34 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the Chandra Bhagat Pharma IPO Retail Individual Investors (RII) are offered 9,50,000 shares while in Gian Life Care IPO retail investors are offered 9,50,000 shares. Qualified Institutional Buyers (QIB) are offered in Chandra Bhagat Pharma IPO and in Gian Life Care IPO.
| Chandra Bhagat Pharma IPO | Gian Life Care IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 1,00,000 shares | 72,000 shares |
| QIB | ||
| NII | 9,50,000 shares | 6,72,000 shares |
| RII | 9,50,000 shares | 6,72,000 shares |
| Employee | ||
| Others | ||
| Total | 19,00,000 shares | 13,44,000 shares |
Chandra Bhagat Pharma IPO subscribed 1.65x in total, whereas Gian Life Care IPO subscribed 1.34x.
| Chandra Bhagat Pharma IPO | Gian Life Care IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.87x | 1.91x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.44x | 0.78x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.65x | 1.34x |
